|
|
||||||||
1 Laboratory of Cellular Biochemistry, Veterinary Medical Sciences/Animal Resource Sciences, The University of Tokyo, Tokyo 113-8657, Japan
2 Department of Medicine (Hematology), Albert Einstein College of Medicine, Bronx, New York 10461, USA
3 Department of Molecular Genetics, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
4 Department of Molecular Genetics, Albert Einstein College of Medicine, Bronx, New York 10461, USA
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
CpG islands have long been recognized as unmethylated regions in normal cells and tissues, except at loci undergoing X inactivation or genomic imprinting. CpG islands are defined as sequences where the length is > 200 bp, the (G+C) content (%GC) is > 50% and the ratio of observed to expected CpG dinucleotide frequencies (CpGobs/CpGexp) is > 0.6 (Gardiner-Garden & Frommer 1987). Most housekeeping genes and almost half of tissue-specifically expressed genes have CpG islands at their promoters (Gardiner-Garden & Frommer 1987; Larsen et al. 1992).
The frequent observation of T-DMRs in tissues (Futscher et al. 2002; Shiota 2004; Kitamura et al. 2007) indicates that the dogma that CpG islands are always unmethylated fails to represent the complexity of cytosine methylation in mammals. In addition to systematic searches for T-DMRs, there are many reports of DNA methylation at CpG-rich regions including CpG islands (De Smet et al. 1999; Strichman-Almashanu et al. 2002; Rakyan et al. 2004; Song et al. 2005). In general, T-DMRs in CpG islands are restricted to subregions within the CpG island sequences. For example, the T-DMR of the Sphk1 gene, which is conserved in mouse, rat and human, occupies ~200 bp at the edge of a 3.7-kb CpG island, a proportion of less than 10% of the entire CpG island (Imamura et al. 2001, 2004). Such T-DMRs restricted to a fraction of CpG island have also been found in genes for the endothelin receptor B (Pao et al. 2001) and proopiomelanocortin (Newell-Price et al. 2001). Interestingly, Hisano et al. found that all CpGs in the CpG island of the Tact1/Actl7b gene are methylated in somatic tissues whereas they are unmethylated in germ cells (Hisano et al. 2003). Therefore, another class of CpG islands is likely to exist in which the T-DMR extends throughout the whole CpG island.
Genome-wide analysis of T-DMRs, performed by Restriction Landmark Genomic Scanning (RLGS) using NotI as landmark enzyme focusing on CpG islands, discovered that more than 10% of identified T-DMRs were unmethylated in sperm (Shiota et al. 2002). Based on this information, we identified and characterized several sperm-specific hypomethylated genes in this study. We found that CpG islands associated with these genes were totally unmethylated in the sperm but methylated in kidney and brain and that the T-DMR extended through the whole CpG island at each of these loci. DNA methylation of the CpG island regulates the expression of Ant4/Slc25a31, which belongs to adenine nucleotide translocator (Ant) gene family and is an example of this unique type of whole CpG island T-DMR.
| Results |
|---|
|
|
|---|
Genomic DNA of several tissues and cells had previously been analyzed by RLGS using NotI as a landmark enzyme (Shiota et al. 2002). Since NotI is a methylation-sensitive enzyme, the appearance of RLGS spots indicates hypomethylation at those sites in the tissue. Among 247 sites that were differentially methylated in these tissues and cells, 30 sites were hypomethylated in sperm but methylated in all other tissues and cells examined (Shiota et al. 2002). By matching RLGS profiles with virtual image (Vi)-RLGS images, followed by confirmation with genomic PCR, we could successfully identify the locations of ten sperm-specific hypomethylated sites which were characterized in the present study (Table 1). Nine of the ten sites were contained within CpG islands according to the definition of CpG island by Gardiner-Garden & Frommer 1987, the remaining T-DMR was located in a CpG-rich region that did not meet the CpG island criteria.
|
The question prompted by the results is whether DNA methylation at CpG sites other than at the NotI site within these CpG islands occurs in somatic tissues. To investigate further the methylation status of each of these regions, we analyzed flanking regions of the sperm-specific hypomethylated sites by sodium bisulfite sequencing. We quantified the methylation in sperm, kidney and brain at eight of the loci with sperm-specific hypomethylation (Fig. 1). Seven of the eight regions were methylated throughout the whole CpG island or CpG-rich region in the kidney and/or brain, while one CpG island was methylated only partially. Focusing on the CpG islands, the Stox1 CpG island was methylated at five of the 13 CpGs within the CpG island in kidney, but the other six CpG islands were hypomethylated in the sperm but methylated throughout the entire CpG island in the kidney and/or brain. From these data, we can classify sperm-specifically hypomethylated CpG islands into two categories: those in which part of the CpG island is hypermethylated in somatic tissues and those in which the entire CpG island is hypermethylated. The first one is typical of previously reported T-DMRs, but the second represents a new type of T-DMR involving entire CpG islands in tissues.
|
The DNA methylation status of a CpG island, when located at a promoter region, usually corresponds to the gene expression status. We focused on a CpG island located near the transcription start site of the 1700034J06Rik gene (also known as Slc25a31), consisting of six exons encoding a protein with 320 amino acids (Fig. 2A). The gene maps to chromosome 3B in the Mammalian Gene Collection Program (Strausberg et al. 2002) and is identified as NM_178386. The gene is highly homologous to adenine nucleotide translocator 1 (Ant1, mRNA; 63% identity, amino acid; 87% identity and similarity) and is ontologically annotated with transporter activity (GO:0005215) and mitochondrial inner membrane localization (GO:005743). We refer to this Ant family member as Ant4. At the transcription start site of the Ant4 gene predicted from RefSeq of mRNA (NM_ 178386), we found a dense cluster of CpG dinucleotides of 543 bp in length (–233~+311 relative to TSS), %GC = 63.4 and CpGobs/CpGexp = 0.88. All of the 43 CpGs in the CpG island were completely methylated also in the liver. In addition, nine CpGs further upstream of the CpG island (–343~–556) were also hypermethylated in somatic tissues. In contrast, the same CpGs in the CpG islands and the upstream region were completely unmethylated in the sperm, indicating that the boundary of methylated and unmethylated regions at the Ant4 promoter is located outside of the CpG island.
|
Ant4 mRNA was not detected by RT-PCR in somatic tissues (kidney, liver and brain), indicating a complete suppression of gene expression (Fig. 2B). The all or none expression observed in the Ant4 gene is suggestive of tissue-specific epigenetic regulation of gene expression. Expression of Ant4 was detectable also in the male gonad of 15.5 dpc and 18.5 dpc fetuses (Fig. 2C). Unexpectedly, expression was also observed in the female gonad at 12.5, 15.5 and 18.5 dpc. The expression studies indicate that the expression of Ant4 is specific to the developing male and female gonadal cells (Fig. 2C). In situ hybridization was performed to identify the cell types expressing Ant4 in the testis (Fig. 2D). Signals for Ant4 mRNA were strong in spermatocytes, while they were weakly detectable in round spermatids. The signals were detected only in a minor population of spermatogonia. Ant4 was expressed neither in Sertoli cells nor Leydig cells.
The T-DMR of the Ant4 CpG island is unmethylated in testicular germ cells
From in situ hybridization results, the expression signals were detected in spermatocytes, round spermatids and minor population of spermatogonia; however, the signals did not show uniform distribution. We tested whether DNA methylation status varied among the testicular germ cells. The testicular germ cell samples were collected with the laser micro-dissection of spermatogonia, spermatocytes and spermatids from adult mouse testis. All 43 CpGs in the Ant4 CpG island were completely unmethylated in these three cell types (Fig. 2E). The single clone of spermatogonia in which CpGs were methylated may possibly represent contamination of genomic DNA from a somatic cell. Overall, while Ant4 expression is generally correlated with the methylation status of its promoter CpG island, we also find that demethylation alone is not sufficient to allow expression of the gene in spermatogenic cells.
DNA methylation inhibits Ant4 promoter activity
To test whether DNA methylation is involved in transcriptional repression of the Ant4 gene, we performed a promoter assay. By PCR amplification, Ant4 mRNA was detected neither in embryonic stem (ES) cells nor in embryonic germ (EG) cells (Supplementary Fig. S1A), indicating that the Ant4 gene is repressed in these pluripotent stem cells. However, in multi-potent germ-line stem (mGS) cells, which were established from the testis of neonatal mice (Kanatsu-Shinohara et al. 2004), a weak signal for Ant4 expression could be detected by RT-PCR performed using 35 cycles (Supplementary Fig. S1A). Various levels of DNA methylation at CpGs in the Ant4 CpG island were observed in the ES, EG and mGS cells (Supplementary Fig. S1B). The 5'-region of the CpG island (region 1: –258~+69) showed partial methylation in all three cell types. By contrast, CpGs in the 3'-region of the CpG island (region 2: +101~+247) showed relatively higher methylation in ES and EG cells than those in mGS cells. Although no pattern of DNA methylation distinguishing stem cell lines appears to exist, several CpGs (CpGs nos. 29–31) in region 2 tended to be hypomethylated in mGS cells. Taken together with the result that mGS cells showed weak gene expression, we chose mGS cells as the most suitable for a promoter assay.
To test the effect of DNA methylation on Ant4 transcription, reporter constructs were created consisting of a luciferase gene fused to the 5'-upstream region (–935 to –5 bp) of the Ant4 gene with and without in vitro methylation (pGL3-Ant4-met and pGL3-Ant4-unmet). The reporter construct with the unmethylated 5'-upstream region had promoter activity, with a 16-fold increase over the empty vector construct, while methylation of the same region exhibited only a threefold increase in activity compared to the empty vector (Fig. 3). We conclude that the transcription of the Ant4 gene is regulated by DNA methylation at CpGs in its promoter region.
|
| Discussion |
|---|
|
|
|---|
Focusing on the CpG island of the Ant4 gene, we find the locus to be distinctive in terms of DNA methylation, which involves all of the CpG sites throughout the promoter CpG island in somatic tissues but completely spares the CpG island in germ cells. Thus, the entire Ant4 CpG island is the T-DMR, in contrast with other somatic tissue-specific T-DMRs at the CpG islands of promoters, where the tissue-specific methylation involves only part of the promoter CpG islands (Imamura et al. 2001, 2004; Newell-Price et al. 2001; Pao et al. 2001). Given the fact that DNA methylation levels in Ant4 T-DMR were nearly 100% in the somatic tissues, precluding allelic differences, and that Ant4 gene is located at chromosome 3B, a region not known to harbor imprinted genes, Ant4 is unlikely to be imprinted and is obviously not subject to X chromosome inactivation. Since the CpG island is located at the transcription start site and at the first exon of the Ant4 gene, it is plausible that the expression of Ant4 is controlled by DNA methylation.
Similar to Ant4, the expression of Tact1/Actl7b is restricted to germ cells and is regulated by DNA methylation (Hisano et al. 2003). Since Tact1/Actl7b is an intronless gene, it is likely to have been generated by a retroposition event during gene evolution. By contrast, the Ant4 gene has six exons and five introns and is not a retroposed locus. This indicates that generation of the class of T-DMRs that occupy the whole CpG island is not dependent on an evolutionary history of retrotransposition. To date, several germ cell-specific genes, in addition to Ant4 and Tact1/Actl7b, have been reported to be under the control of DNA methylation; testis-specific H2B histone, TH2B (Choi & Chae 1991); TFIIA
/β-like factor, ALF (Xie et al. 2002); and testis-specific phosphoglycerate kinase, Pgk2 (Geyer et al. 2004); although these genes do not have CpG islands. In germ cells, these genes are expressed after loss of DNA methylation (Xie et al. 2002; Geyer et al. 2004), suggesting that DNA demethylation is important for the regulation of these genes and is involved in germ cell differentiation. In other words, the loss of DNA methylation in germ cell differentiation may be involved in not only the regulation of imprinted genes but also that of non-imprinted genes.
A gene promoter assay using mGS cells indicated that in vitro DNA methylation of the construct suppressed the Ant4 promoter activity, supporting the conclusion that DNA methylation observed in somatic cells represses Ant4 gene expression. The Ant4 T-DMR was unmethylated in the spermatogonia, spermatocytes, spermatids and mature sperm. In the present study, in situ hybridization study showed that Ant4 mRNA was detectable in a minor population of spermatogonia and the expression became strongest in spermatocytes. Given the nearly complete demethylation of the Ant4 T-DMR in spermatogonia, where Ant4 mRNA was barely detectable, we presume that DNA demethylation at the Ant4 T-DMR precedes the onset of Ant4 expression during spermatogenesis.
Male gonads of 12.5 dpc embryos showed a weak expression of Ant4, but the expression levels in the later developmental stages were greater, suggesting that Ant4 expression starts in these later stages of male germ cell development. Interestingly, the expression of Ant4 was also observed in female gonads. Therefore, demethylation of the Ant4 T-DMR appears to occur at the early stages of germ cell differentiation in the fetal period. From this context, it was unexpected that mGS cells as well as EG cells showed hypermethylation at the Ant4 T-DMR, because mGS cells were established from neonatal testicular cells (Kanatsu-Shinohara et al. 2004). Further studies will be needed to identify the cell types expressing Ant4 in fetal gonads and to identify when demethylation is initiated.
Previously, Rodic and colleagues investigated the DNA methylation status of the Ant4 gene locus in ES cells (129/SvJ), embryoid bodies developed from the ES cells, testis and several somatic tissues of BALB/c mice and found that the gene locus was unmethylated specifically in the stem cells and testis (Rodic et al. 2005). Interestingly, they found an increase in DNA methylation levels during differentiation from ES cells into embryoid bodies. In the present study, however, ES cells (C57BL/6Ncrj) showed DNA hypermethylation even at the stem cell stage and undetectable Ant4 gene expression. It is possible that these discordant results are due to the different strains of mice used, or that the culture history of the ES cells used in each case introduced epigenetic variability. Both in the study by Rodic et al. (2005) and in the present study, the Ant4 gene was found to be unmethylated in germ cells, in which it is expressed. The epigenetic characteristics of the Ant4 locus in germ cells are therefore independent of the genetic backgrounds used in these studies.
In conclusion, we identified and characterized a number of loci undergoing germ cell-specific hypomethylation. We identified the Ant4 gene as a locus for which gene expression is under the control of DNA methylation, leading to silencing in somatic cells and possibly contributing to germ cell differentiation during development. The sperm-specific hypomethylated loci define a new class of CpG islands that are hypermethylated at all CpGs in non-expressed somatic tissues. We propose that there are two classes of T-DMRs: T-DMRs involving only part of promoter CpG islands and those that occupy the whole CpG island.
| Experimental procedures |
|---|
|
|
|---|
Embryonic stem (ES) and embryonic germ (EG) cells derived from mice of the same genetic background (C57BL/6NCrj) (Kawase et al. 1994; Labosky et al. 1994) were maintained in DMEM with 15% fetal calf serum (FCS) on a feeder layer as described previously (Shiota et al. 2002). Multi-potent germ-line stem (mGS) cells derived from DBA/2 mouse were cultured as described in a previous study (Kanatsu-Shinohara et al. 2004).
Adult male mice of the C57BL/6NCrj strain (Charles River Japan, Yokohama, Japan) were dissected for tissue preparation under the guidelines for the care and use of laboratory animals (Graduate School of Agriculture and Life Sciences, The University of Tokyo). Sperm sample was collected from vas deferens. All samples were frozen in liquid nitrogen and stored at –80 °C until use.
Micro-dissection from paraffin-embedded testis sections
Paraffin-embedded testes that were prepared from 8-week-old C57BL/6NCrj male mice were sliced into 6-µm sections and stained with Mayer's hematoxylin. Isolation of each spermatogenic cell from the sections was performed using the P.A.L.M. MicroBeam system (P.A.L.M. Microlaser Technologies AG, Bernried, Germany) according to the manufacturer's instructions. Spermatogenic cells were collected (spermatocytes 300 cells, spermatogonia 500 cells and spermatids 1000 cells) and stored at –80 °C until extraction of the genomic DNA.
Genomic DNA and RNA preparation
Genomic DNA was extracted from frozen samples as described previously (Ohgane et al. 1998). Total RNA was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Following the treatment of extracted total RNA with DNase I (TAKARA, Kyoto, Japan), complementary DNA (cDNA) was generated using Superscript III reverse transcriptase (Invitrogen) with random hexamers.
Identification of the sperm-specific unmethylated NotI site by Vi-RLGS and genomic PCR
The sperm-specific unmethylated NotI sites in the mouse genome were explored by comparing the genomic profiles of cells and tissues by the RLGS method (Shiota et al. 2002). The genomic locus was identified by matching the profiles of RLGS and Vi-RLGS as previously described (Matsuyama et al. 2003; Hattori et al. 2004a). Using the sequence information from Vi-RLGS, the genomic location of the NotI site was obtained using BLAST <http://www.ncbi.nlm.nih.gov/genome/seq/MmBlast.html> and the UCSC genome browser <http://genome.ucsc.edu/>. The G+C content and CpG frequency of the genomic DNA was analyzed computationally (CpG-View version 1.5, provided by the National Institute of Infectious Diseases <http://www.nih.go.jp/yoken/genebank/>). The methylation status of the NotI site in the mouse tissues was confirmed by the combination of restriction digestion of genomic DNA and quantitative real-time PCR as described previously (Hattori et al. 2004a). Briefly, genomic DNA extracted from the sperm, kidney and brain was digested with EcoRI and the aliquots were further digested with NotI. DNA methylation at the NotI site is estimated by the amount of PCR fragments amplified from NotI-digested genomic DNA compared with that from NotI-undigested DNA. The amount of initial genomic DNA in the reaction is corrected by the amount of the internal control. Primer sets for quantitative real-time PCR used in this study are listed in Supplementary Table S1. For all samples, independent PCRs in duplicate were performed at least 3 times.
Bisulfite genomic sequencing
Bisulfite genomic sequencing was performed as previously described (Hattori et al. 2004b). Briefly, genomic DNA was digested with EcoRI and denatured with NaOH for 15 min at 37 °C. After the incubation, sodium metabisulfite, pH 5.0, and hydroquinone were added to final concentrations of 2.0 M and 0.5 mM, respectively, and the mixture was further incubated in the dark for 16 h at 55 °C. The modified DNA was purified using the Wizard DNA Clean-Up system (Promega, Madison, WI), and the bisulfite reaction was terminated with NaOH at a final concentration of 0.3 M for 15 min at 37 °C. The solution was then neutralized by adding NH4OAc, pH 7.0, to a final concentration of 3.0 M. The ethanol-precipitated DNA was resuspended in water. The primer sets that we used in this study were described in the Supplementary Table S2. The amplified PCR fragments were cloned into pGEM-T easy vector (Promega) and analyzed by sequencing.
RT-PCR
To detect the expression of Ant4 and β-actin, PCR was performed using rTaq polymerase (TOYOBO, Osaka, Japan). Primer sequences are as follows: 5'-TCCAACATGTCGAACGAATCC-3' and 5'-GAACAGAGACACCAAACCCTT-3' for Ant4 and 5'-GACAACGTCTCCTGCATGTGCAAAG-3' and 5'-TTCACGGTTGGCCTTAGGGTTCAG-3' for β-actin. PCR reactions were performed at 94 °C, 4 min; 30 cycles of 94 °C, 30 s; 58 °C, 30 s; 72 °C, 1 min; final extension 72 °C, 10 min.
Gene promoter assays
The 5'-flanking region of the Ant4 was isolated by genomic PCR with specific primers: 5'-GCTAGCACCCAGCTATGAACCCTGTG-3' and 5'-AAGCTTGAACTGGAAAACCGCTTCAG-3' and ligated into pGEM-T easy vector for cloning. The resulting construct containing 5'-flanking region of the Ant4 was re-digested with NheI and HindIII and subcloned into pGL3-Basic vector (Promega) digested with the same enzymes. Amplification of the construct was carried out using dam–, dcm– bacterial strain, SCS110 (Stratagene, CA), to avoid methylation of the construct. The construct was dissected with BglII and HindIII whose restriction sites are located at the inside of the amplified 5'-flanking region by the genomic PCR and one primer sequence, respectively. The resultant fragment (–935 to –5) was isolated and methylated in vitro with SssI methylase (New England BioLabs, Ipswich, MA) as described previously (Tomikawa et al. 2006). The methylated fragment was re-ligated with the empty pGL3-Basic vector that had been digested with BglII and HindIII in advance. Unmethylated control vector was constructed by the same method without the in vitro methylation step. These methylated and unmethylated control vectors, designated pGL3-Ant4-met and pGL3-Ant4-unmet, respectively, were linearized by BamHI digestion and purified by size selection with agarose gel electrophoresis to exclude non-ligated pGL3-Basic vector and those ligated with concatemer fragments. These purified constructs were not amplified in bacteria after the ligation step in order to maintain the regional methylation status. Completion of in vitro methylation of Ant4 5'-flanking region in pGL3-Ant4-met was confirmed by the bisulfite sequencing method as described above.
The mGS cells plated at 5 x 104 cells/well in a 24-well dish were incubated for 24 h, then transfected transiently with 373.8 ng of the luciferase reporter construct using Lipofectamine 2000 Reagent (Invitrogen). To normalize the luciferase activity, 26.2 ng of a control plasmid with Renilla luciferase sequence (pRL-TK; Promega) were co-transfected to each well. After culturing for 48 h, the activities of both luciferases were determined by means of a Dual Luciferase Reporter System (Promega) according to the manufacturer's instructions. Assays were performed 3 times each in duplicate.
In situ hybridization
In situ hybridization was performed as previously described (Hoshino et al. 1999) under contract by Genostaff (Tokyo, Japan). In brief, a 261-bp cDNA fragment corresponding to the nucleotide positions 672–932 of mouse 1700034J06Rik cDNA (GENBANK accession number NM_178386) was amplified by RT-PCR. The amplified product was cloned into pGEM-T easy vector (Promega), and was used for generation of sense or antisense digoxigenin (DIG)-labeled RNA probes by using DIG RNA labeling Mix (Roche Molecular Biochemicals, Tokyo, Japan). Paraffin-embedded testis sections (6 µm) of 8-week-old C57BL/6NCrj male mice were subjected to hybridization with the antisense or sense probes at the concentration of 100 ng/mL in the Probe Diluent (Genostaff) at 60 °C overnight. Hybridized probes were detected by alkaline phosphatase-conjugated anti-DIG IgG and visualized with NBT/BCIP solution (Roche Molecular Biochemicals). Then the sections were counterstained with Kernechtrot stain solution (Muto Chemical, Tokyo, Japan), dehydrated and mounted with Malinol (Muto Chemical).
| Acknowledgements |
|---|
| Footnotes |
|---|
aThese authors contributed equally to this work.
| References |
|---|
|
|
|---|
Choi, Y.C. & Chae, C.B. (1991) DNA hypomethylation and germ cell-specific expression of testis-specific H2B histone gene. J. Biol. Chem. 266, 20504–20511.
De Smet, C., Lurquin, C., Lethe, B., Martelange, V. & Boon, T. (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol. Cell. Biol. 19, 7327–7335.
Futscher, B.W., Oshiro, M.M., Wozniak, R.J., Holtan, N., Hanigan, C.L., Duan, H. & Domann, F.E. (2002) Role for DNA methylation in the control of cell type specific maspin expression. Nat. Genet. 31, 175–179.[CrossRef][Medline]
Gardiner-Garden, M. & Frommer, M. (1987) CpG islands in vertebrate genomes. J. Mol. Biol. 196, 261–282.[CrossRef][Medline]
Geyer, C.B., Kiefer, C.M., Yang, T.P. & McCarrey, J.R. (2004) Ontogeny of a demethylation domain and its relationship to activation of tissue-specific transcription. Biol. Reprod. 71, 837–844.
Hattori, N., Abe, T., Hattori, N., Suzuki, M., Matsuyama, T., Yoshida, S., Li, E. & Shiota, K. (2004a) Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells. Genome Res. 14, 1733–1740.
Hattori, N., Nishino, K., Ko, Y.G., Hattori, N., Ohgane, J., Tanaka, S. & Shiota, K. (2004b) Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. J. Biol. Chem. 279, 17063–17069.
Hisano, M., Ohta, H., Nishimune, Y. & Nozaki, M. (2003) Methylation of CpG dinucleotides in the open reading frame of a testicular germ cell-specific intronless gene, Tact1/Actl7b, represses its expression in somatic cells. Nucleic Acids Res. 31, 4797–4804.
Hoshino, M., Sone, M., Fukata, M., Kuroda, S., Kaibuchi, K., Nabeshima, Y. & Hama, C. (1999) Identification of the stef gene that encodes a novel guanine nucleotide exchange factor specific for Rac1. J. Biol. Chem. 274, 17837–17844.
Imamura, T., Miyauchi-Senda, N., Tanaka, S. & Shiota, K. (2004) Identification of genetic and epigenetic similarities of SPHK1/Sphk1 in mammals. J. Vet. Med. Sci. 66, 1387–1393.[CrossRef][Medline]
Imamura, T., Ohgane, J., Ito, S., Ogawa, T., Hattori, N., Tanaka, S. & Shiota, K. (2001) CpG island of rat sphingosine kinase-1 gene: tissue-dependent DNA methylation status and multiple alternative first exons. Genomics 76, 117–125.[CrossRef][Medline]
Kanatsu-Shinohara, M., Inoue, K., Lee, J. et al. (2004) Generation of pluripotent stem cells from neonatal mouse testis. Cell 119, 1001–1012.[CrossRef][Medline]
Kawase, E., Suemori, H., Takahashi, N., Okazaki, K., Hashimoto, K. & Nakatsuji, N. (1994) Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int. J. Dev. Biol. 38, 385–390.[Medline]
Kitamura, E., Igarashi, J., Morohashi, A., Hida, N., Oinuma, T., Nemoto, N., Song, F., Ghosh, S., Held, W.A., Yoshida-Noro, C. & Nagase, H. (2007) Analysis of tissue-specific differentially methylated regions (TDMs) in humans. Genomics 89, 326–337.[CrossRef][Medline]
Ko, Y.G., Nishino, K., Hattori, N., Arai, Y., Tanaka, S. & Shiota, K. (2005) Stage-by-stage change in DNA methylation status of Dnmt1 locus during mouse early development. J. Biol. Chem. 280, 9627–9634.
Labosky, P.A., Barlow, D.P. & Hogan, B.L. (1994) Mouse embryonic germ (EG) cell lines: transmission through the germline and differences in the methylation imprint of insulin-like growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines. Development 120, 3197–3204.[Abstract]
Larsen, F., Gundersen, G., Lopez, R. & Prydz, H. (1992) CpG islands as gene markers in the human genome. Genomics 13, 1095–1107.[CrossRef][Medline]
Matsuyama, T., Kimura, M.T., Koike, K., Abe, T., Nakano, T., Asami, T., Ebisuzaki, T., Held, W.A., Yoshida, S. & Nagase, H. (2003) Global methylation screening in the Arabidopsis thaliana and Mus musculus genome: applications of virtual image restriction landmark genomic scanning (Vi-RLGS). Nucleic Acids Res. 31, 4490–4496.
Newell-Price, J., King, P. & Clark, A.J. (2001) The CpG island promoter of the human proopiomelanocortin gene is methylated in nonexpressing normal tissue and tumors and represses expression. Mol. Endocrinol. 15, 338–348.
Nishino, K., Hattori, N., Tanaka, S. & Shiota, K. (2004) DNA methylation-mediated control of Sry gene expression in mouse gonadal development. J. Biol. Chem. 279, 22306–22313.
Ohgane, J., Aikawa, J., Ogura, A., Hattori, N., Ogawa, T. & Shiota, K. (1998) Analysis of CpG islands of trophoblast giant cells by restriction landmark genomic scanning. Dev. Genet. 22, 132–140.[CrossRef][Medline]
Pao, M.M., Tsutsumi, M., Liang, G., Uzvolgyi, E., Gonzales, F.A. & Jones, P.A. (2001) The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum. Mol. Genet. 10, 903–910.
Rakyan, V.K., Hildmann, T., Novik, K.L., Lewin, J., Tost, J., Cox, A.V., Andrews, T.D., Howe, K.L., Otto, T., Olek, A., Fischer, J., Gut, I.G., Berlin, K. & Beck, S. (2004) DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project. PLoS Biol. 2, e405.[CrossRef][Medline]
Rodic, N., Oka, M., Hamazaki, T., Murawski, M.R., Jorgensen, M., Maatouk, D.M., Resnick, J.L., Li, E. & Terada, N. (2005) DNA methylation is required for silencing of ant4, an adenine nucleotide translocase selectively expressed in mouse embryonic stem cells and germ cells. Stem Cells 23, 1314–1323.
Shiota, K. (2004) DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet. Genome Res. 105, 325–334.[CrossRef][Medline]
Shiota, K., Kogo, Y., Ohgane, J., Imamura, T., Urano, A., Nishino, K., Tanaka, S. & Hattori, N. (2002) Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells 7, 961–969.[Abstract]
Song, F., Smith, J.F., Kimura, M.T., Morrow, A.D., Matsuyama, T., Nagase, H. & Held, W.A. (2005) Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc. Natl. Acad. Sci. USA 102, 3336–3341.
Strausberg, R.L., Feingold, E.A., Grouse, L.H. et al. (2002) Generation and initial analysis of more than 15 000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. USA 99, 16899–16903.
Strichman-Almashanu, L.Z., Lee, R.S., Onyango, P.O., Perlman, E., Flam, F., Frieman, M.B. & Feinberg, A.P. (2002) A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Res. 12, 543–554.
Tomikawa, J., Fukatsu, K., Tanaka, S. & Shiota, K. (2006) DNA methylation-dependent epigenetic regulation of dimethylarginine dimethylaminohydrolase 2 gene in trophoblast cell lineage. J. Biol. Chem. 281, 12163–12169.
Weeks, R.J. & Morison, I.M. (2006) Detailed methylation analysis of CpG islands on human chromosome region 9p21. Genes Chromosomes Cancer 45, 357–364.[CrossRef][Medline]
Xie, W., Han, S., Khan, M. & DeJong, J. (2002) Regulation of ALF gene expression in somatic and male germ line tissues involves partial and site-specific patterns of methylation. J. Biol. Chem. 277, 17765–17774.
Accepted: 9 August 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |